Clare Midgley is the chief communications officer at the Broad Institute of MIT and Harvard. In that role, she is responsible for enhancing the awareness and reputation of the Broad among national and international audiences, particularly in non-scientific circles.
Midgley came to the Broad with over twenty-five years’ experience managing corporate communications, brand strategy, public relations, investor relations, and crisis management, primarily in the biotechnology, life sciences, and high technology industries. Before joining the institute, she was president of Midgley Advisors, a management and communications consulting practice, where she helped world-class companies and institutions achieve growth objectives by enhancing the value of their brand and by translating leadership vision into tangible organizational strategies. Prior to that, she served as vice president of global corporate affairs and later vice president of corporate strategy at Millennium Pharmaceuticals, Inc., a genomics-based biopharmaceutical company. In those roles, she advised the company’s executive leaders and Board of Directors on business strategies and strategic communications, acted as corporate spokesperson, and was part of the launch team for Velcade, a novel cancer therapeutic.
Midgley is a longstanding member of the Board of Directors and former co-chair of the development committee of the Schwartz Center for Compassionate Healthcare, a not-for-profit organization focused on strengthening the relationships between patients and caregivers. She holds a B.A. in speech communication from Bloomsburg University.